Consolidated Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]
Balance at Dec. 31, 2013	$ 6,310.6	$ 2.6	$ 4,000.6	$ 7,789.4	$ 300.9	$ (5,785.7)	$ 2.8
Balance, shares at Dec. 31, 2013		264.3				(94.5)
Net earnings	719.2			720.3			(1.1)
Other comprehensive income (loss)	(262.7)				(262.8)		0.1
Cash dividends declared	(148.6)			(148.6)
Stock compensation plans	333.7	$ 0.1	330.1	1.0		$ 2.5
Stock compensation plans, shares		4.1
Share repurchases	(400.5)					$ (400.5)
Share repurchases, shares						(4.2)
Balance at Dec. 31, 2014	6,551.7	$ 2.7	4,330.7	8,362.1	38.1	$ (6,183.7)	1.8
Balance, shares at Dec. 31, 2014		268.4				(98.7)
Net earnings	146.2			147.0			(0.8)
Other comprehensive income (loss)	(366.6)				(367.1)		0.5
Cash dividends declared	(164.4)			(164.4)
Stock compensation plans	149.8		142.2	3.0		$ 4.6
Stock compensation plans, shares		1.6				0.1
Share repurchases	(150.0)					$ (150.0)
Share repurchases, shares						(1.4)
Biomet merger consideration	3,722.7	$ 0.3	3,722.4
Biomet merger consideration, shares		32.7
Balance at Dec. 31, 2015	9,889.4	$ 3.0	8,195.3	8,347.7	(329.0)	$ (6,329.1)	1.5
Balance, shares at Dec. 31, 2015		302.7				(100.0)
Net earnings	304.6			305.9			(1.3)
Other comprehensive income (loss)	(104.2)				(105.0)		0.8
Cash dividends declared	(191.9)			(191.9)
Stock compensation plans	187.5	$ 0.1	173.2	5.4		$ 8.8
Stock compensation plans, shares		2.0				0.1
Share repurchases	$ (415.5)					$ (415.5)
Share repurchases, shares	(4.2)					(4.2)
Balance at Dec. 31, 2016	$ 9,669.9	$ 3.1	$ 8,368.5	$ 8,467.1	$ (434.0)	$ (6,735.8)	$ 1.0
Balance, shares at Dec. 31, 2016		304.7				(104.1)